Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 3/20 | 0.55 |
| ▸ | NOS1 | P29475 | 3/20 | 0.55 |
| ▸ | NOS2 | P35228 | 3/20 | 0.55 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | DRD1 | P21728 | 2/20 | 0.37 |
| ▸ | DRD5 | P21918 | 2/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | F12 | P00748 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
| ▸ | NCF1 | P14598 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19122728 | 0.78 | — | — | |
| SCHEMBL1280654 | 0.73 | CD44 (0.48) | NOS3NOS1NOS2DYRK1ACYP2A6 | |
| SCHEMBL16658453 | 0.71 | NOS2 (0.92) | NOS3NOS1NOS2DYRK1ADRD4 | |
| SCHEMBL394598 | 0.71 | NOS2 (1.00) | NOS3NOS1NOS2DYRK1AROCK1 | |
| SCHEMBL250734 | 0.71 | CYP2A6 (0.65) | CYP2A6DRD2DRD1DRD5DRD4 | |
| SCHEMBL2771201 | 0.70 | CYP2A6 (0.48) | CYP2A6DRD2DRD1DRD5DRD4 | |
| Hydrochloric Acid SCHEMBL16650985 | 0.69 | NOS2 (0.88) | NOS3NOS1NOS2DYRK1ADRD4 | |
| SCHEMBL31379414 | 0.69 | CYP2A6 (0.46) | DYRK1ACYP2A6DRD2DRD1DRD5 | |
| SCHEMBL1754061 | 0.67 | NOS3 (0.58) | NOS3NOS1NOS2DYRK1AF12 | |
| SCHEMBL10339508 | 0.67 | DYRK1A (1.00) | NOS3NOS2DYRK1AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050245503-A1 | Therapeutic heterocycles | ASTRAZENECA AB (SE) | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245503-A1 | Therapeutic heterocycles | OPRK1, RECQL, OPRM1 | NOS3 2886/4885NOS1 3620/4885NOS2 2998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.